Premium
Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocvtic leukemia (sANLL)
Author(s) -
Johansson B.,
Mertens F.,
Heim S.,
Kristoffersson U.,
Mitelrnan F.
Publication year - 1991
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/j.1600-0609.1991.tb00556.x
Subject(s) - cytogenetics , karyotype , biology , leukemia , myelodysplastic syndromes , pathology , chromosome , genetics , medicine , bone marrow , immunology , gene
76 cases of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL) were cytogenetically analyzed. Among the 36 sMDS patients, 13 (36%) had only normal karyotypes whereas 23 (64%) displayed clonal chromosomal abnormalities. The most common aberrations were −7, 5q‐, −5, and +8. In 10 patients (43% of the cytogenetically aberrant cases), clones with only one anomaly, mostly 5q −or − 7, were found. Of the 40 sANLL patients, normal karyotypes were detected in 10 (25%). Among the 30 (75%) abnormal cases, the most frequent aberrations were −7, −5, +8, 7q‐, − 17, and +21. 12 patients (40%) had clones with single abnormalities, most often − 7. In 4 sANLL patients cytogenetically unrelated clones were detected. A survey of all previously published secondary hematologic neoplasias reveals that the most frequent abnormalities in sMDS are −7 (41%), 5q‐ (28%), and − 5 (11x), followed by der(21q), + 8, 7q‐, der(12p), t(1;7), − 12, − 17, der(17p), der(3p), der(6p), and − 18. Clones with single aberrations have been found in 45 % of the cases and cytogenetically unrelated clones have been described in 6%. The most common abnormalities in sANLL are −7 (38%), 5q‐ (17%), −5 (15%), +8 (13%), and − 17 (llx), followed by der(3q), der(11q), der(12p), −21, 7q‐, − 18, der(3p), der(17p), +21, der(21q), der(6p), and − 16. 38% of the sANLL patients have had clones with only one aberration and 3% have had unrelated clones. The frequencies of these nonrandom abnormalities in sMDS and sANLL are thus remarkably similar ‐ the only exception appears to be 5q ‐, which is more common in sMDS. Also the mean number of abnormalities per case is similar − 5.3 in sMDS and 5.6 in sANLL. When the incidences of characteristic cytogenetic abnormalities were correlated with the type of previous therapy, − 7 was found to be more frequent in sMDS and sANLL patients who had been exposed to chemotherapy whereas 5q ‐was associated with previous exposure to ionizing radiation in sMDS patients.